A few years ago, routine lab tests showed that Susan Glickman Weinberg, then a 65-year-old clinical social worker in Los Angeles, had a hemoglobin A1C reading of 5.8 percent, barely above normal. “This is considered prediabetes,” her internist told her. A1C measures how much sugar has been circulating in the bloodstream over time. If her…
Just when it seemed that a new gene therapy for sickle cell disease was sailing toward success, the company developing the treatment found that two patients now have cancer and halted the trial. A patient who was treated five and a half years ago has developed myelodysplastic syndrome, a form of cancer that is often…
New compound targets neurons that initiate voluntary movement After 60 days of treatment, diseased brain cells look like healthy cells More research needed before clinical trial can be initiated CHICAGO and EVANSTON— Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a…
DALLAS, Feb. 23, 2021 — Women face many female-specific risks for heart disease and stroke, including pregnancy, physical and emotional stress, sleep patterns and many physiological factors, according to multiple studies highlighted in this year’s Go Red for Women® special issue of the Journal of the American Heart Association, published online today. “Although cardiovascular disease…
NEW YORK, NY, February 23, 2021–JDRF, the leading global organization funding type 1 diabetes (T1D) research, announces, in collaboration with the Harvard Stem Cell Institute, the launch of the JDRF Center of Excellence in New England. Led by Harvard Stem Cell Institute co-director Douglas Melton, Ph.D. and JDRF scientific staff leader Esther Latres, Ph.D., Assistant…
Oak Brook, IL – The Society for Laboratory Automation and Screening (SLAS) is pleased to announce a collaboration with the Pistoia Alliance to support and promote innovative life sciences start-ups and emerging companies. The SLAS Ignite Program is a multi-pronged initiative to promote innovation, pioneering research, start-up and emerging companies and their products, and…
Lugano, Switzerland, 23 February 2021 – The ESMO Targeted Anticancer Therapies Congress 2021, designed for basic scientists, physicians and translational researchers belonging to academic settings, industry and regulatory agencies will be held as a virtual meeting. (1) The scientific programme will provide new data and insightful presentations in the area of drug discovery and development…